Vogeloside exhibits significant biological activity, particularly in the field of anti-inflammatory and immunomodulatory applications. It has been studied for its ability to suppress pro-inflammatory cytokines, making it a candidate for development in treatments targeting chronic inflammatory diseases such as arthritis and inflammatory bowel disease. Additionally, vogeloside demonstrates antioxidant properties, which contribute to cellular protection against oxidative stress, a factor in aging and neurodegenerative disorders. Research also suggests potential antiviral effects, especially against certain enveloped viruses, due to its influence on membrane stability and viral entry inhibition. These combined activities position vogeloside as a promising lead compound in pharmaceuticals, particularly for multi-target therapies in inflammation-related conditions.